{"name": "Neurocrine Biosciences",
 "permalink": "neurocrine-biosciences",
 "crunchbase_url": "http://www.crunchbase.com/company/neurocrine-biosciences",
 "homepage_url": "http://www.neurocrine.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1992,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@neurocrine.com",
 "phone_number": "858-617-7600",
 "description": "",
 "created_at": "Fri Dec 18 03:43:36 UTC 2009",
 "updated_at": "Fri Dec 18 03:43:36 UTC 2009",
 "overview": "\u003Cp\u003ENeurocrine Biosciences, Inc. engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company develops drugs for endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome, insomnia, and other neurological and endocrine related diseases and disorders. Its products in clinical development comprise Elagolix, a Phase II product for Endometriosis; CRF1 Antagonist, a phase II product for mood disorders; CRF2 Peptide Agonist, a phase II drug for Cardiovascular related diseases; CRF1 Antagonist, a Phase I product for treating Mood Disorders and Irritable Bowel Syndrome; and Elagolix, a Phase I product for treating Benign Prostatic Hyperplasia and Uterine Fibroids. The company\u00e2\u20ac\u2122s research programs include Vesicular Monoamine Transporter 2 Inhibitor for movement disorders and schizophrenia; Glucose Dependent Insulin Secretagogues for type II diabetes; Antiepileptic drugs for epilepsy and bipolar disorder; and GnRH Antagonists for hormone dependent diseases and oncology. It has strategic alliances with GlaxoSmithKline to develop and commercialize CRF antagonists for psychiatric, neurological, and gastrointestinal diseases; and Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize indiplon in Japan. Neurocrine Biosciences, Inc. was founded in 1992 and is based in San Diego, California.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       48],
      "assets/images/resized/0007/0258/70258v1-max-150x150.png"],
     [[190,
       62],
      "assets/images/resized/0007/0258/70258v1-max-250x250.png"],
     [[190,
       62],
      "assets/images/resized/0007/0258/70258v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chairman",
    "person":
     {"first_name": "William",
      "last_name": "Rastetter",
      "permalink": "william-rastetter",
      "image": null}},
   {"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Kevin",
      "last_name": "C. Gorman",
      "permalink": "kevin-c-gorman",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Timothy",
      "last_name": "P. Coughlin",
      "permalink": "timothy-p-coughlin",
      "image": null}},
   {"is_past": true,
    "title": "Founder \u0026 CEO",
    "person":
     {"first_name": "Larry",
      "last_name": "Bock",
      "permalink": "larry-bock",
      "image":
       {"available_sizes":
         [[[110,
            150],
           "assets/images/resized/0009/9950/99950v1-max-150x150.jpg"],
          [[183,
            250],
           "assets/images/resized/0009/9950/99950v1-max-250x250.jpg"],
          [[330,
            450],
           "assets/images/resized/0009/9950/99950v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Director",
    "person":
     {"first_name": "David",
      "last_name": "Schnell",
      "permalink": "david-schnell",
      "image": null}},
   {"is_past": true,
    "title": "Associate Director, Marketing",
    "person":
     {"first_name": "Mark",
      "last_name": "Mahmood",
      "permalink": "mark-mahmood",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0026/6872/266872v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0026/6872/266872v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0026/6872/266872v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Various Positions",
    "person":
     {"first_name": "Kimberly",
      "last_name": "Hebert",
      "permalink": "kimberly-hebert",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$10M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://phx.corporate-ir.net/phoenix.zhtml?c=68817\u0026p=irol-newsArticle\u0026highlight=\u0026ID=1366951",
    "source_description": "Neurocrine Announces Sale of 4,784,689 Shares of Common Stock, to Raise Proceeds of $10 Million",
    "raised_amount": 10000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 12,
    "funded_day": 17,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Venrock",
         "permalink": "venrock",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],
             [[351,
               123],
              "assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "12780 El Camino Real",
    "address2": "",
    "zip_code": "92130",
    "city": "San Diego",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0007/0257/70257v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0007/0257/70257v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0007/0257/70257v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}